Table 2

Laboratory findings at 24 weeks, end of treatment and one month after end of treatment.

Baseline
 24 weeks
 P
 End of treatment (ETR) 12 months
 P
 1 month after end of treatment
 p
ALT UI/ml (mean ± SD)
 169 ± 129
 131 ± 61
 NS
 95 ± 61
 NS
 79 ± 75
 NS
HCV-RNA × 106geq/ml (mean ± SD)
 28.3 ± 36.6
 9.2 ± 12.4
 0.66
 1.4 ± 1.6
 0.07
 39.07 ± 20.22
 NS

Bruno et al. BMC Infectious Diseases 2002 2:17   doi:10.1186/1471-2334-2-17